Correlation Between BioNTech and Tscan Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BioNTech and Tscan Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioNTech and Tscan Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioNTech SE and Tscan Therapeutics, you can compare the effects of market volatilities on BioNTech and Tscan Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioNTech with a short position of Tscan Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioNTech and Tscan Therapeutics.

Diversification Opportunities for BioNTech and Tscan Therapeutics

-0.16
  Correlation Coefficient

Good diversification

The 3 months correlation between BioNTech and Tscan is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding BioNTech SE and Tscan Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tscan Therapeutics and BioNTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioNTech SE are associated (or correlated) with Tscan Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tscan Therapeutics has no effect on the direction of BioNTech i.e., BioNTech and Tscan Therapeutics go up and down completely randomly.

Pair Corralation between BioNTech and Tscan Therapeutics

Given the investment horizon of 90 days BioNTech SE is expected to generate 0.71 times more return on investment than Tscan Therapeutics. However, BioNTech SE is 1.41 times less risky than Tscan Therapeutics. It trades about 0.1 of its potential returns per unit of risk. Tscan Therapeutics is currently generating about -0.05 per unit of risk. If you would invest  11,326  in BioNTech SE on August 28, 2024 and sell it today you would earn a total of  750.00  from holding BioNTech SE or generate 6.62% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

BioNTech SE  vs.  Tscan Therapeutics

 Performance 
       Timeline  
BioNTech SE 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in BioNTech SE are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, BioNTech showed solid returns over the last few months and may actually be approaching a breakup point.
Tscan Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tscan Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

BioNTech and Tscan Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BioNTech and Tscan Therapeutics

The main advantage of trading using opposite BioNTech and Tscan Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioNTech position performs unexpectedly, Tscan Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tscan Therapeutics will offset losses from the drop in Tscan Therapeutics' long position.
The idea behind BioNTech SE and Tscan Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
FinTech Suite
Use AI to screen and filter profitable investment opportunities